http://mindray.com
迈瑞公司是中国领先的高科技医疗设备研发制造厂商，同时也是全球医用诊断设备的创新领导者之一。自1991年成立以来，迈瑞公司始终致力于面向临床医疗设备的研发和制造，产品涵盖生命信息与支持、临床检验、数字超声、放射影像四大领域，将性能与价格完美平衡的医疗电子产品带到世界每一角落。时至今日，迈瑞公司在全球范围内的销售已扩展至140多个国家和地区。
迈瑞公司总部位于中国深圳，员工4600余名，在中国30个主要城市以及美国、加拿大、英国、荷兰、土耳其、印度、墨西哥等国家设立了分支机构，在世界各地建立了强大的分销和服务网络。2006年9月迈瑞公司作为中国首家医疗设备企业在美国纽交所成功上市，10月获科技部批准正式挂牌成立“国家医用诊断仪器工程技术研究中心”。担纲引领民族医疗设备发展之重任，迈瑞公司正朝着世界级优秀企业的宏伟目标跨越发展。
Mindray was founded in 1991 in Shenzhen, China, with a mission to deliver high-quality, competitively priced medical devices to make healthcare more accessible and affordable around the world. Over the last 15 years, we have become a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence. According to Frost & Sullivan, in 2006 we attained leading market share in China both by units sold and revenue for the sale of patient monitoring devices. In addition to patient monitoring devices, we also believe that we hold leading market share in China in both the diagnostic laboratory instrument and grayscale ultrasound imaging system segments.
Our success has been deeply rooted in our commitment to invest approximately 10% of our revenues into R&D every year. With more than 800 engineers on staff, we have built a world-class platform that capitalizes on low-cost China based R&D operations and a culture that is driven by ingenuity, and both individual and team performance. We currently offer more than 40 products across three product segments including patient monitoring devices, diagnostic laboratory instruments and ultrasound imaging systems. In 2006, along with our newly released BeneView T8, WATO-50, and DC-6, we released the BC-5500, the first five-part hematology analyzer developed by a Chinese company. We expect to continue to introduce six to seven new products each year to broaden our market reach. We are confident that our growing comprehensive portfolio of high-quality, affordable products will allow us to continue gaining market share both domestically and internationally.
In China, we have distributed products to approximately 27,000 hospitals, clinics, and healthcare facilities; and at the end of 2006 we had sold over 200,000 devices in over 140 countries worldwide. We began exporting our products for the first time in 2000; and in the second half of 2006, revenues generated from international markets exceeded domestic revenues for the first time in our operating history.
At the end of 2006, we had a total of approximately 2,700 employees worldwide, and we are expanding our distribution network, sales and sales support staff to bring our products closer to end users. We currently have 29 local sales and service offices in China, as well as sales and service offices in Boston, Istanbul, London, Mumbai, Seattle and Vancouver.
Our Company's American Depositary Shares (ADSs) are listed on the New York Stock Exchange (NYSE) under the symbol MR.
